Talazoparib

Talazoparib is used alone to treat certain types of breast cancer that has spread within the breast or to other areas of the body. Talazoparib is also used with enzalutamide (Xtandi) to treat certain types of prostate cancer that has spread to other parts of the body in men and who have not been helped by certain medical and surgical treatments that decrease testosterone levels. Talazoparib is in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by stopping or slowing the growth of cancer cells.

🔔 How should this medicine be used?

Talazoparib comes as a capsule to take by mouth. It is usually taken with or without food once a day. Take talazoparib at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take talazoparib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the capsules whole; do not dissolve or open them.

If you vomit after taking talazoparib, do not take another dose. Continue your regular dosing schedule.

Your doctor may decrease your dose of talazoparib, or permanently or temporarily stop your treatment, if you experience certain side effects. Be sure to tell your doctor how you are feeling during your treatment with talazoparib. Continue to take talazoparib even if you feel well. Do not stop taking talazoparib without talking to your doctor.

If you are taking talazoparib with enzalutamide (Xtandi) to treat prostate cancer and your doctor has prescribed another medication such as degarelix (Firmagon), goserelin (Zoladex), histrelin (Supprelin LA, Vantas), leuprolide (Eligard, Lupron, in Lupaneta Pack), or triptorelin (Trelstar, Triptodur) to treat your prostate cancer, you will need to continue receiving this medication during your treatment with talazoparib.

Long wait times are often cited as a downfall of universal healthcare systems, but wait times in America have reached a new high, too. The average time to make a physician appointment as a new patient in 15 major U.S. cities is now 24 days, up 30% in just 3 years (2014 to 2018) according to physician recruiting firm Merritt Hawkins.

Ask your pharmacist or doctor for a copy of the manufacturer’s information for the patient.

🔔 Other uses for this medicine

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

See also  Rivastigmine